Business Name: |
Alexander Infusion Pharmacy |
Contact Person: |
Peter Piacquadio, Manager |
Address: |
75 Nassau Terminal Road, New Hyde Park, New York 11040 |
Phone Number: |
(718) 445-5400 |
Website Address: |
avantihealth.com |
Annual Revenue (USD): |
$5.000.000 to $9.999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
|
SIC Code: |
5912 |
NAICS Code: |
4461100 |
Share This Business: |
|
Related Businesses: |
Genovese Drug Stores Inc - New Hyde Park, NY 11040 S G S Pharmacy Inc - New Hyde Park, NY 11040 New Hyde Park Pharmacy - New Hyde Park, NY 11040 Lakeville Drug Corp - New Hyde Park, NY 11040 S & D Pharmacy Inc - New Hyde Park, NY 11040 Lakeville Pharmacy - New Hyde Park, NY 11040 Avanti Healthcare Service - New Hyde Park, NY 11040 Invite Health - New Hyde Park, NY 11040 Langdale Drug & Surgical - New Hyde Park, NY 11040 Cvs Pharmacy Inc - New Hyde Park, NY 11040 Deckuy Chemist - New Hyde Park, NY 11040 Rite Aid - New Hyde Park, NY 11040 Walgreens - New Hyde Park, NY 11040 Walgreens - New Hyde Park, NY 11040 New Hyde Park Chemists Inc - New Hyde Park, NY 11040 Tower Drugs Inc - New Hyde Park, NY 11040 Cvs/Pharmacy - New Hyde Park, NY 11040 |
The company Alexander Infusion Pharmacy provides B2C services in the form of from its single location in New York.
1 to 4 employees work for Alexander Infusion Pharmacy, and the business now earns $5.000.000 to $9.999.999 per annum.
Alexander Infusion Pharmacy was launched in 0 and is classified under SIC code and category 5912 , and NAICS number and grouping 4461100 .
To contact Alexander Infusion Pharmacy, please call Peter Piacquadio, Manager with the phone number (718) 445-5400 or visit its single location at 75 Nassau Terminal Road in New Hyde Park, New York 11040.
The location of the single location can also be found using the coordinates 40.735251,-73.672753.
Read more details about this business on the webpage avantihealth.com or follow the company’s social media accounts, on Twitter and on Facebook.